EUR 18.74
(-1.16%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 1.90 EUR | 158.28% |
2022 | -3.26 EUR | -225.87% |
2021 | 2.59 EUR | 78.62% |
2020 | 1.45 EUR | -51.18% |
2019 | 2.97 EUR | -20.16% |
2018 | 3.72 EUR | 0.81% |
2017 | 3.69 EUR | 58.37% |
2016 | 2.33 EUR | -27.41% |
2015 | 3.21 EUR | 55.07% |
2014 | 2.07 EUR | 27.78% |
2013 | 1.62 EUR | 1.25% |
2012 | 1.60 EUR | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | 0.87 EUR | 0.0% |
2023 FY | - EUR | 158.28% |
2023 Q2 | 0.17 EUR | 0.0% |
2023 Q4 | 1.80 EUR | 0.0% |
2022 Q2 | 0.26 EUR | 0.0% |
2022 FY | - EUR | -225.87% |
2022 Q4 | -3.52 EUR | 0.0% |
2021 FY | - EUR | 78.62% |
2021 Q4 | 0.73 EUR | 0.0% |
2021 Q2 | 1.86 EUR | 0.0% |
2020 FY | - EUR | -51.18% |
2020 Q2 | 0.65 EUR | 0.0% |
2020 Q4 | 0.76 EUR | 0.0% |
2019 Q2 | 1.51 EUR | 0.0% |
2019 FY | - EUR | -20.16% |
2019 Q4 | 1.46 EUR | 0.0% |
2018 Q4 | 1.93 EUR | 0.0% |
2018 FY | - EUR | 0.81% |
2018 Q2 | 1.77 EUR | 0.0% |
2017 Q2 | 1.82 EUR | 0.0% |
2017 Q4 | 1.83 EUR | 0.0% |
2017 FY | - EUR | 58.37% |
2016 Q4 | 1.34 EUR | 0.0% |
2016 FY | - EUR | -27.41% |
2016 Q2 | 0.95 EUR | 0.0% |
2015 Q2 | 1.62 EUR | 0.0% |
2015 FY | - EUR | 55.07% |
2015 Q4 | 1.51 EUR | 0.0% |
2014 Q2 | 0.95 EUR | 0.0% |
2014 FY | - EUR | 27.78% |
2014 Q4 | 1.12 EUR | 0.0% |
2013 Q4 | 0.83 EUR | 0.0% |
2013 FY | - EUR | 1.25% |
2013 Q2 | 0.79 EUR | 0.0% |
2012 Q4 | 0.26 EUR | 0.0% |
2012 Q3 | 0.26 EUR | 0.0% |
2012 FY | - EUR | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Cegedim SA | -0.54 EUR | 451.852% |
Nexus AG | 1.39 EUR | -36.691% |
Bastide Le Confort Médical SA | -0.12 EUR | 1683.333% |
Revenio Group Oyj | 0.72 EUR | -163.889% |
Drägerwerk AG & Co. KGaA | 5.89 EUR | 67.742% |
Sartorius Aktiengesellschaft | 3.00 EUR | 36.667% |
LNA Santé SA | 2.29 EUR | 17.031% |
Siemens Healthineers AG | 1.74 EUR | -9.195% |
Medios AG | 0.79 EUR | -140.506% |
Equasens Société anonyme | 3.13 EUR | 39.297% |
Stratec SE | 1.07 EUR | -77.57% |